Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03627351 · ClinicalTrials.gov registry record
Sensory Evaluation of the Taste of Pediatric Medicines
A clinical trial, sponsored by Monell Chemical Senses Center.
- Completed
- Registry status
- 154
- Enrollment target
NCT03627351: Completed study, sponsored by Monell Chemical Senses Center.
NCT03627351 is a clinical trial that has completed, run by Monell Chemical Senses Center. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03627351 has completed, sponsored by Monell Chemical Senses Center.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
Study Summary
The investigators will conduct a systematic study of the sensory perception of a diverse set of commonly used pediatric liquid medications and excipients in tandem with an equally complete genetic analysis of the adult sensory panelists to investigate the relationship between genetic variation and individual differences in the perceived flavor (taste, smell, irritation) of pediatric medicines. The flavor of each medicine and excipient will be measured individually using both cognitively demanding methods unsuitable for young children and simpler measures validated for use by children. Salivary DNA samples will be collected to carry out genome wide association study (GWAS).
Primary Outcome
Flavor ratings of each pediatric medicine and excipient as assessed by the general labelled magnitude scale \[gLMS\]; each medicine and each excipient is rated individually; range 0 \[minimum, no flavor\] to 100 \[maximum; strongest flavor rating\]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2024-03-01 |
What the finished NCT03627351 record still lists
NCT03627351 is an observational study that tracks outcomes without assigning an intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03627351 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03627351 about?
NCT03627351 is a clinical study titled "Sensory Evaluation of the Taste of Pediatric Medicines". The investigators will conduct a systematic study of the sensory perception of a diverse set of commonly used pediatric liquid medications and excipients in tandem with an equally complete genetic analysis of the adult sensory panelists to investigate the relationship between genetic variation and i...
What is the current status of trial NCT03627351?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2018-09-01. Estimated completion is 2024-03-01.
Who is sponsoring clinical trial NCT03627351?
This trial is sponsored by Monell Chemical Senses Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI